Meningioma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
* It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=2945461 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref> | * It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=2945461 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref> | ||
* Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199 }} </ref> | * Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199 }} </ref> | ||
===Incidence=== | ===Incidence=== | ||
Revision as of 15:21, 28 February 2019
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Meningioma epidemiology and demographics |
|
Risk calculators and risk factors for Meningioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1] The incidence of meningioma is approximately 7.62 per 100,000 individuals in the United States.[2] Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[3] Females are more commonly affected with meningiomas than males.[1] Meningioma usually affects individuals of the African American race. Caucasian and Latin American individuals are less likely to develop meningioma.
Epidemiology and Demographics
Prevalence
- The prevalence of meningioma is estimated to be 97.5 cases per 100,000 individuals in the United States. There are over 170,000 diagnosed cases in the United States.[1]
- It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.[1]
- Meningioma is the second most common primary brain tumor worldwide.[4]
Incidence
- The incidence of meningiomas annually is approximately 7.62 per 100,000 individuals in the United States. The incidence of benign meningiomas is about 7.18, about 0.32 for borderline malignant meningiomas, and about 0.12 for malignant meningiomas.[2]
- The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.[3]
Age
- Meningiomas can occur at any age but is mostly seen with advancing age. [2]
- Meningiomas are uncommon among patients before the age of 40 and should raise suspicion of neurofibromatosis type 2 (NF2) syndrome when found among young patients.[5]
Gender
- Females are more commonly affected with meningiomas than males.[1]
- The female to male ratio is approximately 2 to 1.
- The incidence of meningioma among females is approximately 8.36 per 100,000 individuals in the United States, with that of males being 3.61 per 100,000 individuals.[1]
- The female to male ratio of meningiomas may be inverted among affected patients who are younger than 15 years of age.[1]
- Atypical and malignant meningiomas have a slight male predominace.[1]
Race
- Meningioma usually affects individuals of the black race. Caucasian and Latin American individuals are less likely to develop meningioma.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Wiemels J, Wrensch M, Claus EB (2010). "Epidemiology and etiology of meningioma". J Neurooncol. 99 (3): 307–14. doi:10.1007/s11060-010-0386-3. PMC 2945461. PMID 20821343.
- ↑ 2.0 2.1 2.2 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015). "Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act". Cancer. 121 (14): 2400–10. doi:10.1002/cncr.29379. PMID 25872752.
- ↑ 3.0 3.1 Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015
- ↑ Chamberlain MC, Barnholtz-Sloan JS (2011). "Medical treatment of recurrent meningiomas". Expert Rev Neurother. 11 (10): 1425–32. doi:10.1586/ern.11.38. PMID 21955199.
- ↑ Meningeoma. Radiopaedia(2015)http://radiopaedia.org/articles/meningioma Accessed on September, 25 2015